This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
BRACAnalysis -2
{ "resourceType": "Observation", "id": "ob-genetics-3-2", "text": { "status": "generated", "div": "<div><p><b>Generated Narrative with Details</b></p><p><b>id</b>: ob-genetics-3-2</p><p><b>status</b>: final</p><p><b>code</b>: BRCA2 gene mutation analysis <span>(Details : {LOINC code '38530-2' = 'BCRA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal', given as 'BRCA2 gene mutation analysis'})</span></p><p><b>subject</b>: <a>Marry Chalmers(MRN: 12345)</a></p><p><b>effective</b>: 26/05/2015 3:30:10 PM</p><p><b>value</b>: Positive <span>(Details : {SNOMED CT code '10828004' = '10828004', given as 'Positive'})</span></p><p><b>method</b>: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc <span>(Details : {http://www.ncbi.nlm.nih.gov/gtr/ code 'GTR000521311.1' = '??', given as 'BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc'})</span></p><h3>Components</h3><table><tr><td>-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td>*</td><td>Genetic disease sequence variation interpretation <span>(Details : {LOINC code '53037-8' = 'Genetic disease sequence variation interpretation [interpretation] in Blood or Tissue by Molecular genetics method', given as 'Genetic disease sequence variation interpretation'})</span></td><td>Pathogenic <span>(Details : {[not stated] code 'LA6668-3' = '??', given as 'Pathogenic'})</span></td></tr></table></div>" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/observation-geneticsSequence", "valueReference": { "reference": "#off2" } }, { "extension": [ { "url": "genomeBuild", "valueCodeableConcept": { "text": "GRCh 38" } }, { "url": "name", "valueCodeableConcept": { "text": "185delAG" } } ], "url": "http://hl7.org/fhir/StructureDefinition/observation-geneticsVariationHGVS" } ], "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "38530-2", "display": "BRCA2 gene mutation analysis" } ] }, "subject": { "reference": "Patient/example", "display": "Marry Chalmers(MRN: 12345)" }, "effectiveDateTime": "2015-05-26T15:30:10+01:00", "valueCodeableConcept": { "coding": [ { "system": "http://snomed.info/sct", "code": "10828004", "display": "Positive" } ] }, "method": { "coding": [ { "system": "http://www.ncbi.nlm.nih.gov/gtr/", "code": "GTR000521311.1", "display": "BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc" } ] }, "component": [ { "code": { "coding": [ { "system": "http://loinc.org", "code": "53037-8", "display": "Genetic disease sequence variation interpretation" } ] }, "valueCodeableConcept": { "coding": [ { "code": "LA6668-3", "display": "Pathogenic" } ] } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.